AMEND wishes to support research and is provides grants when funds allow to enable medical researchers to supplement an existing project or pump-prime new research ideas. Applicants must be registered members of AMEND and the successful projects must be specifically directed to the study of endocrine tumours, within the context of the Charity’s remit.  Awards are currently only available to projects carried out within the United Kingdom and Eire.  Grants are usually to the value of £10,000 each, although larger amounts have been awarded.  Current specific awards include the following, although applications concerning other diseases/tumours are also invited:

The Nick Fayers Award for MEN1 Research forms part of the annual grants programme.  It was set up in memory of the late Nick Fayers who had MEN1, and whose friends and family raised £100,000 for AMEND in 2018/19.  These grants are available until further notice for one or more research projects directly related to MEN1 tumours.

ACC Support UK Awards may be granted for projects related to adrenocortical cancer if funds allow.

The 2020 Research Fund Award Round is now open (total fund £30,000).  Deadline April 2020

For further information and criteria, please view the application form:

AMEND is a National Institute for Health Research (NIHR) Non-Commercial Partner

Appropriate research studies funded through AMEND’s Research Fund are now automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to:

Please note that to be eligible for NIHR CRN support any research study we fund must also meet the standard study eligibility criteria, namely that it:

Current and Past Award(s)